Companies / Metagenomi Therapeutics, Inc. / Activity
Activity — Metagenomi Therapeutics, Inc.
6 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Irish Jian CEO | Sell | Common Stock | $2.6K | -2K -0.48% | 333,770 0.88% of shares | low |
| Mar 5, 2026 | Wapnick Pamela Executive | Sell | Common Stock | $2.5K | -2K -0.84% | 187,375 0.50% of shares | low |
| Mar 5, 2026 | Wein Matthew Executive | Sell | Common Stock | $771 | -482 -0.42% | 114,549 0.30% of shares | low |
| Dec 5, 2025 | Irish Jian CEO | Gift | Common Stock | $0 | -228K -40.52% | 335,377 0.89% of shares | low |
| Jun 9, 2026 | Dere Willard H Director | Grant | Stock Option (Right to Buy) | — | +21K | 21,000 0.06% of shares | low |
| Jun 9, 2026 | Bjerkholt Eric Director | Grant | Stock Option (Right to Buy) | — | +21K | 21,000 0.06% of shares | low |